PRPS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.517830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.199700E-02
Normal-vs-Stage2
1.993780E-01
Normal-vs-Stage3
2.316400E-02
Normal-vs-Stage4
3.122400E-01
Stage1-vs-Stage2
1.657970E-01
Stage1-vs-Stage3
5.227600E-01
Stage1-vs-Stage4
5.121200E-01
Stage2-vs-Stage3
7.633900E-02
Stage2-vs-Stage4
7.775200E-01
Stage3-vs-Stage4
3.023000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.721590E-01
Normal-vs-AfricanAmerican
5.817900E-02
Normal-vs-Asian
1.244610E-01
Caucasian-vs-AfricanAmerican
6.339600E-01
Caucasian-vs-Asian
7.198600E-01
AfricanAmerican-vs-Asian
8.338200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.374230E-01
Normal-vs-Female
1.854980E-01
Male-vs-Female
2.838600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.938000E-02
Normal-vs-Age(41-60Yrs)
2.374000E-01
Normal-vs-Age(61-80Yrs)
1.289780E-01
Normal-vs-Age(81-100Yrs)
2.527800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.028430E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.240200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.040200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.038300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.922400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.855600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.298600E-01
Normal-vs-Daily Drinker
1.120990E-01
Normal-vs-Weekly Drinker
3.162400E-01
Normal-vs-Occasional Drinker
3.298200E-01
Normal-vs-Social Drinker
1.365630E-01
Non Drinker-vs-Daily Drinker
4.000000E-01
Non Drinker-vs-Weekly Drinker
8.555000E-01
Non Drinker-vs-Occasional Drinker
8.101800E-01
Non Drinker-vs-Social Drinker
7.972400E-01
Daily Drinker-vs-Weekly Drinker
3.924200E-01
Daily Drinker-vs-Occasional Drinker
3.440200E-01
Daily Drinker-vs-Social Drinker
2.881400E-01
Weekly Drinker-vs-Occasional Drinker
9.707200E-01
Weekly Drinker-vs-Social Drinker
9.675000E-01
Occasional Drinker-vs-Social Drinker
9.980400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.507200E-01
Normal-vs-Grade 2
8.050200E-02
Normal-vs-Grade 3
5.509800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.395880E-02
Grade 1-vs-Grade 3
1.230330E-02
Grade 1-vs-Grade 4
4.507200E-01
Grade 2-vs-Grade 3
6.290200E-01
Grade 2-vs-Grade 4
8.050200E-02
Grade 3-vs-Grade 4
5.509800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.046000E-01
Normal-vs-NonDiabetic
1.457430E-01
Diabetic-vs-NonDiabetic
8.112800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.835000E-01
Normal-vs-NoPancreatitis
1.591050E-01
Pancreatitis-vs-NoPancreatitis
4.069600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.056200E-02
Normal-vs-N1
2.034600E-01
N0-vs-N1
7.237700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.259000E-01
Normal-vs-TP53-NonMutant
1.820210E-01
TP53-Mutant-vs-TP53-NonMutant
2.944900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
